Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Oslo, Norway, 8 March 2024: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company") on 28 September 2023 regarding the approval of a registration document (the "Registration Document") which was prepared to be used as a base prospectus for the purpose of listing new shares in the Company related to the convertible bond facility with Atlas Special Opportunities LLC ("Atlas").
Further reference is made to the stock exchange announcements published by the Company on 4 and 5 March 2024, announcing that Atlas had by notice of conversion, requested conversion of convertible bonds into a total of 171,154 new shares in the Company. A total of 99,548 of the new shares (the "New Shares") were issued at a separate ISIN pending publication of a prospectus.
The Financial Supervisory Authority of Norway (Nw.: Finanstilsynet) has today approved a securities note, a supplement to the Registration Document and a summary (together with the Registration Document, referred to as the "Prospectus") prepared for the listing of the New Shares.
The Prospectus is available at the Company's website https://www.circio.com/en/section/investors/prospectus/.
***